BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30107580)

  • 1. Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
    Jaber M; Ewelt C; Wölfer J; Brokinkel B; Thomas C; Hasselblatt M; Grauer O; Stummer W
    Neurosurgery; 2019 Jun; 84(6):1214-1224. PubMed ID: 30107580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers.
    Hosmann A; Jaber M; Roetzer-Pejrimovsky T; Timelthaler G; Borkovec M; Kiesel B; Wadiura LI; Millesi M; Mercea PA; Phillips J; Hervey-Jumper S; Berghoff AS; Hainfellner JA; Berger MS; Stummer W; Widhalm G
    J Neurosurg; 2023 May; 138(5):1281-1290. PubMed ID: 36115057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors.
    Jaber M; Wölfer J; Ewelt C; Holling M; Hasselblatt M; Niederstadt T; Zoubi T; Weckesser M; Stummer W
    Neurosurgery; 2016 Mar; 78(3):401-11; discussion 411. PubMed ID: 26366972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
    Kaneko S; Suero Molina E; Sporns P; Schipmann S; Black D; Stummer W
    J Neurosurg; 2022 Jan; 136(1):9-15. PubMed ID: 34144512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
    Ewelt C; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Stoffels G; Stummer W
    Clin Neurol Neurosurg; 2011 Sep; 113(7):541-7. PubMed ID: 21507562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    Bashir A; Brennum J; Broholm H; Law I
    J Neurosurg; 2018 Apr; 130(2):451-464. PubMed ID: 29624154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
    Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
    J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era.
    Tom MC; Varra V; Leyrer CM; Park DY; Chao ST; Yu JS; Suh JH; Reddy CA; Balagamwala EH; Broughman JR; Kotagal KA; Vogelbaum MA; Barnett GH; Ahluwalia MS; Peereboom DM; Prayson RA; Stevens GHJ; Murphy ES
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1099-1105. PubMed ID: 31022510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas.
    Stockhammer F; Misch M; Horn P; Koch A; Fonyuy N; Plotkin M
    Acta Neurochir (Wien); 2009 Nov; 151(11):1377-83. PubMed ID: 19639250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement.
    Widhalm G; Wolfsberger S; Minchev G; Woehrer A; Krssak M; Czech T; Prayer D; Asenbaum S; Hainfellner JA; Knosp E
    Cancer; 2010 Mar; 116(6):1545-52. PubMed ID: 20108311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Corticosteroids and Antiepileptic Drugs on Visible 5-Aminolevulinic Acid Fluorescence in a Series of Initially Suspected Low-Grade Gliomas Including World Health Organization Grade II, III, and IV Gliomas.
    Wadiura LI; Mischkulnig M; Hosmann A; Borkovec M; Kiesel B; Rötzer T; Mercea PA; Furtner J; Hervey-Jumper S; Rössler K; Berger MS; Widhalm G
    World Neurosurg; 2020 May; 137():e437-e446. PubMed ID: 32045726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers.
    Hosmann A; Millesi M; Wadiura LI; Kiesel B; Mercea PA; Mischkulnig M; Borkovec M; Furtner J; Roetzer T; Wolfsberger S; Phillips JJ; Berghoff AS; Hervey-Jumper S; Berger MS; Widhalm G
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas.
    Widhalm G; Olson J; Weller J; Bravo J; Han SJ; Phillips J; Hervey-Jumper SL; Chang SM; Roberts DW; Berger MS
    J Neurosurg; 2019 May; ():1-10. PubMed ID: 31075771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas.
    Floeth FW; Sabel M; Ewelt C; Stummer W; Felsberg J; Reifenberger G; Steiger HJ; Stoffels G; Coenen HH; Langen KJ
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):731-41. PubMed ID: 21153408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute.
    Turkoglu E; Gurer B; Sanli AM; Dolgun H; Gurses L; Oral NA; Donmez T; Sekerci Z
    Clin Neurol Neurosurg; 2013 Dec; 115(12):2508-13. PubMed ID: 24225484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
    Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
    J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
    Bø HK; Solheim O; Kvistad KA; Berntsen EM; Torp SH; Skjulsvik AJ; Reinertsen I; Iversen DH; Unsgård G; Jakola AS
    J Neurosurg; 2019 Feb; 132(2):518-529. PubMed ID: 30717057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
    Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
    World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of O-(2-[
    Kertels O; Kessler AF; Mihovilovic MI; Stolzenburg A; Linsenmann T; Samnick S; Brändlein S; Monoranu CM; Ernestus RI; Buck AK; Löhr M; Lapa C
    Mol Imaging Biol; 2019 Dec; 21(6):1174-1181. PubMed ID: 30977078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.